← SynDRA
BRD-K04923131
SynDRA canonical compound SYN0062661 — structure-anchored drug synonym record
Clinical phase
Preclinical
Primary target(s)
ALOX5 | GSK3A | GSK3B
Mechanism of action
glycogen synthase kinase inhibitor | lipoxygenase inhibitor
All known targets
ALOX5
GSK3A
GSK3B
Mechanisms of action (all sources)
glycogen synthase kinase inhibitor
lipoxygenase inhibitor
Cross-references
LINCS BRD: BRD-K04923131
Synonyms
GSK-3-inhibitor-IX
Look up BRD-K04923131 in the interactive SynDRA portal →